Orion Corporation

    113 Aufrufe 113 0 Kommentare 0 Kommentare

    Managers’ transactions – Henrik Stenqvist

    ORION CORPORATION
    MANAGERS’ TRANSACTIONS
    2 MAY 2025 at 11.45 EEST
            

    Orion Corporation: Managers’ transactions – Henrik Stenqvist

    Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.

    Orion Oyj - Managers' Transactions
    ____________________________________________
    Person subject to the notification requirement
    Name: Henrik Stenqvist
    Position: Member of the Board/Deputy member
    Issuer: Orion Oyj
    LEI: 74370029VAHCXDR7B745
    Notification type: INITIAL NOTIFICATION
    Reference number: 106243/4/4

    ____________________________________________
    Transaction date: 2025-04-30
    Venue: OFF-EXCHANGE LIIKETOIMET (XOFF)
    Instrument type: SHARE
    ISIN: FI0009014377
    Nature of transaction: RECEIPT OF A SHARE-BASED INCENTIVE

    Transaction details
    (1): Volume: 415 Unit price: 0 EUR

    Aggregated transactions (1):
    Volume: 415 Volume weighted average price: 0 EUR

    Orion Corporation

    Liisa Hurme

    President and CEO
        Olli Huotari

    Executive Vice President,
    Corporate Functions
     

                                                     

    Publisher:
    Orion Corporation
    Communications
    Orionintie 1A, FI-02200 Espoo, Finland
    http://www.orionpharma.com

    Orion is a globally operating Nordic pharmaceutical company – a builder of well-being for over a hundred years. We develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. Orion has an extensive portfolio of proprietary and generic medicines and consumer health products. The core therapy areas of our pharmaceutical R&D are oncology and pain. Proprietary products developed by Orion are used to treat cancer, neurological diseases and respiratory diseases, among others. In 2024 Orion's net sales amounted to EUR 1,542 million and the company employed about 3,700 professionals worldwide, dedicated to building well-being. Orion's A and B shares are listed on Nasdaq Helsinki.






    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    Orion Corporation Managers’ transactions – Henrik Stenqvist ORION CORPORATION MANAGERS’ TRANSACTIONS 2 MAY 2025 at 11.45 EEST         Orion Corporation: Managers’ transactions – Henrik Stenqvist Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, …